SciELO - Scientific Electronic Library Online

 
vol.47 número3Early rebleeding and death at 6 weeks in alcoholic cirrhotic patients with acute variceal bleeding treated with emergency endoscopic injection sclerotherapy índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Em processo de indexaçãoSimilares em Google

Compartilhar


South African Journal of Surgery

versão On-line ISSN 2078-5151

S. Afr. j. surg. vol.47 no.3 Cape Town Ago. 2009

 

EDITORIAL

 

Taking the tension out of portal hypertension

 

J. E. J. Krige

Surgical Gastroenterology Department of Surgery University of Cape Town

 

 

“Full text available only in PDF format”

 

 

REFERENCES

1. Bornman PC, Krige JEJ, Terblanche J. Management of oesophageal varices. Lancet 1994; 343: 1079-1084.         [ Links ]

2. Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding. Lancet 2003; 361: 952-954.         [ Links ]

3. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22: 332-354.         [ Links ]

4. Krige JEJ, Beningfield SJ, Shaw JM. Management of bleeding oesophageal varices. In: Johnson C, Taylor I, eds. Recent Advances in Surgery. Vol. 30. London: Royal Society of Medicine, 2007: 105-125.         [ Links ]

5. Krige JE, Beckingham IJ. Portal hypertension: varices. BMJ 2001; 322: 348-351.         [ Links ]

6. Langer B. Treatment of portal hypertension. World J Surg 1994; 18: 169-170.         [ Links ]

7. Krige JE, Shaw JM, Bornman PC. The evolving role of endoscopic treatment of esophageal varices. World J Surg 2005; 29: 966-973.         [ Links ]

8. Villanueva C, Balanzó J. Variceal bleeding: pharmacological treatment and prophylactic strategies. Drugs 2008; 68: 2303-2324.         [ Links ]

9. Tait IS, Krige JEJ, Terblanche J. Endoscopic band ligation of oesophageal varices. Br J Surg 1999; 86: 812-817.         [ Links ]

10. Krige JEJ, Botha JF, Bornman PC. Endoscopic variceal ligation for bleeding esophageal varices. Digestive Endoscopy 1999; 11: 315-320.         [ Links ]

11. Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005; 41: 386-400.         [ Links ]

12. Luca A, D'Amico G, La Galla R, Midiri M, Morabito A, Pagliaro L. TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology 1999; 212: 411-421.         [ Links ]

13. Rosemurgy AS, Bloomston M, Clark WC, Thometz DP, Zervos EE. H-graft portacaval shunts versus TIPS: ten-year follow-up of a randomized trial with comparison to predicted survivals. Ann Surg 2005; 241: 238-246.         [ Links ]

14. Keeffe EB. Liver transplantation: current status and novel approaches to liver replacement. Gastroenterology 2001; 120: 749-762.         [ Links ]

15. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44: 217-231.         [ Links ]

16. Nidegger D, Ragot S, Berthelémy P, et al. Cirrhosis and bleeding: the need for very early management. J Hepatol 2003; 39: 509-514.         [ Links ]

17. Krige JE, Bornman PC. Endoscopic treatment of oesophageal varices. S Afr J Surg 2000; 38: 82-88.         [ Links ]

18. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371: 838-851.         [ Links ]

19. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44: 217-231.         [ Links ]

20. Treiber G, Csepregi A, Malfertheiner P. The pathophysiology of portal hypertension. Dig Dis 2005; 23: 6-10.         [ Links ]

21. Henderson JM, Barnes DS, Geisinger MA. Portal hypertension. Curr Probl Surg 1998; 35: 381-452.         [ Links ]

22. Block K, Reichelderfer M. Portal Hypertension: A Multidisciplinary Approach to Current Clinical Management. Armonk, NY: Futura Publishing Company, 1998.         [ Links ]

23. Knechtle S. Integrating a Multidisciplinary Approach to Management of Portal Hypertension. Armonk, NY: Futura Publishing Company, 1998.         [ Links ]

24. D'Amico G, Luca A. Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding. Baillieres Clin Gastroenterol 1997; 11: 243-256.         [ Links ]

25. Garcia-Pagan JC, De Gottardi A, Bosch J. Review article: the modern management of portal hypertension – primary and secondary prophylaxis of variceal bleeding in cirrhotic patients. Aliment Pharmacol Ther 2008; 28: 178-186.         [ Links ]

26. Feu F, García-Pagán JC, Bosch J, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995; 346: 1056-1059.         [ Links ]

27. D'Amico G, De Franchis R; Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003; 38: 599-612.         [ Links ]

28. Ben-Ari Z, Cardin F, McCormick AP, et al. A predictive model for failure to control bleeding during acute variceal haemorrhage. J Hepatol 1999; 31: 443-450.         [ Links ]

29. Siringo S, McCormick PA, Mistry P, et al. Prognostic significance of the white nipple sign in variceal bleeding. Gastrointest Endosc 1991; 37: 51-55.         [ Links ]

30. Zhao C, Chen SB, Zhou JP, et al. Prognosis of hepatic cirrhosis patients with esophageal or gastric variceal hemorrhage: multivariate analysis. Hepatobiliary Pancreat Dis Int 2002; 1: 416-419.         [ Links ]

31. Jalan R, Hayes PC. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut 2000; 46: Suppl III, iii1–iii15.         [ Links ]

32. Poynard T, Lebrec D, Hillon P, et al. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a prospective study of factors associated with rebleeding. Hepatology 1987; 7: 447-451.         [ Links ]

33. Thomopoulos K, Theocharis G, Mimidis K, et al. Improved survival of patients presenting with acute variceal bleeding. Prognostic indicators of short- and long-term mortality. Dig Liver Dis 2006; 38: 899-904.         [ Links ]

34. Sanders DS, Carter MJ, Goodchap RJ, et al. Prospective validation of the Rockall risk scoring system for upper GI hemorrhage in subgroups of patients with varices and peptic ulcers. Am J Gastroenterol 2002; 97: 630-635.         [ Links ]

35. Bosch J, Berzigotti A, Garcia-Pagan JC, et al. The management of portal hypertension: rational basis, available treatments and future options. J Hepatol 2008; 48: Suppl 1, S68-92.         [ Links ]

36. Bhasin DK, Siyad I. Variceal bleeding and portal hypertension: new lights on old horizon. Endoscopy 2004; 36: 120-129.         [ Links ]

37. Goulis J, Armonis A, Patch D, et al. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 1998; 27: 1207-1212.         [ Links ]

38. Bernard B, Grangé JD, Khac EN, et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 1999; 29: 1655-1661.         [ Links ]

39. Moitinho E, Escorsell A, Bandi JC, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 1999; 117: 626-631.         [ Links ]

40. Abraldes JG, Angermayr B, Bosch J. The management of portal hypertension. Clin Liver Dis 2005; 9: 685-713, vii.         [ Links ]

41. Monescillo A, Martínez-Lagares F, Ruiz-del-Arbol L, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 2004; 40: 793-801.         [ Links ]

42. Avgerinos A, Armonis A, Stefanidis G, et al. Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis. Hepatology 2004; 39: 1623-1630.         [ Links ]

43. Bosch J. Vascular deterioration in cirrhosis: the big picture. J Clin Gastroenterol 2007; 41: Suppl 3, S247-S253.         [ Links ]

44. del Olmo JA, Peña A, Serra MA, et al. Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. J Hepatol 2000; 32: 19-24.         [ Links ]

45. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43: 167-176.         [ Links ]

46. Bosch J, Abraldes JG, Groszmann R. Current management of portal hypertension. Hepatology 2003; 38: S54-S68.         [ Links ]

47. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43: 167-176.         [ Links ]

48. Carbonell N, Pauwels A, Serfaty L, et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004; 40: 652-659.         [ Links ]

49. Le Moine O, Adler M, Bourgeois N, et al. Factors related to early mortality in cirrhotic patients bleeding from varices and treated by urgent sclerotherapy. Gut 1992; 33: 1381-1385.         [ Links ]

50. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800-809.         [ Links ]

51. Graffeo M, Buffoli F, Lanzani G, et al. Survival after endoscopic sclerotherapy for esophageal varices in cirrhotics. Am J Gastroenterol 1994; 89: 1815-1822.         [ Links ]

52. Prindiville T, Miller M, Trudeau W. Prognostic indicators in acute variceal hemorrhage after treatment by schlerotherapy. Am J Gastroenterol 1987; 82: 655-659.         [ Links ]

53. Yang MT, Chen HS, Lee HC, et al. Risk factors and survival of early bleeding after esophageal variceal ligation. Hepatogastroenterology 2007; 54: 1705-1709.         [ Links ]

54. Amitrano L, Guardascione MA, Bennato R, et al. MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices. J Hepatol 2005; 42: 820-825.         [ Links ]

55. Cárdenas A, Ginès P, Uriz J, et al. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology 2001; 34: 671-676.         [ Links ]

56. Garden OJ, Motyl H, Gilmour WH, et al. Prediction of outcome following acute variceal haemorrhage. Br J Surg 1985; 72: 91-95.         [ Links ]

57. Lata J, Husová L, Juránková J, et al. Factors participating in the development and mortality of variceal bleeding in portal hypertension – possible effects of the kidney damage and malnutrition. Hepatogastroenterology 2006; 53: 420-425.         [ Links ]

58. Chalasani N, Kahi C, Francois F, et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003; 98: 653-659.         [ Links ]

59. Gatta A, Merkel C, Amodio P, et al. Development and validation of a prognostic index predicting death after upper gastrointestinal bleeding in patients with liver cirrhosis: a multicenter study. Am J Gastroenterol 1994; 89: 1528-1536.         [ Links ]

60. Hori S, Takaki A, Okada H, et al. Endoscopic therapy for bleeding esophageal varices improves the outcome of Child C cirrhotic patients. J Gastroenterol Hepatol 2006; 21: 1704-1709.         [ Links ]

61. Srikureja W, Kyulo NL, Runyon BA, et al. MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis. J Hepatol 2005; 42: 700-706.         [ Links ]

62. Lo GH, Chen WC, Chen MH, et al. The characteristics and the prognosis for patients presenting with actively bleeding esophageal varices at endoscopy. Gastrointest Endosc 2004; 60: 714-720.         [ Links ]

63. Cholongitas E, Papatheodoridis GV, Vangeli M, et al. Systematic review: The model for end-stage liver disease – should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther 2005; 22: 1079-1089.         [ Links ]

64. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007; 45: 797-805.         [ Links ]

65. Bambha K, Kim WR, Pedersen R, Bida JP, Kremers WK, Kamath PS. Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis. Gut 2008; 57: 814-820.         [ Links ]

66. Huo TI, Lee SD, Lin HC. Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond. Liver Int 2008; 28: 606-613.         [ Links ]

67. Mac Mathuna P, Westaby D, Williams R. Taking the tension out of the portal system. An approach to the management of portal hypertension in the 1990s. Scand J Gastroenterol Suppl 1990; 175: 131-145.         [ Links ]

68. de Franchis R, Pascal JP, Ancona E, et al. Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol 1992; 15: 256-261.         [ Links ]

69. de Franchis R. Developing consensus in portal hypertension. J Hepatol 1996; 25: 390-394.         [ Links ]

70. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33: 846-852.         [ Links ]

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License